In this issue:
- The Vascular Annual Meeting (VAM) is nigh, and the specialty is grappling with several pressing issues across a number of fronts. We take a look at three in particular: diversity, equity and inclusion; appropriate use and the future of vascular surgery; and a proposed cut to Medicare that would hit the vascular specialty particularly hard (p. 1, 4 and 6–7)
- William Shutze, MD, and colleagues in Dallas delve into an area of study little-seen in the vascular literature—that of prosthetic referral and possible survival benefits. Shutze et al uncovered some intriguing findings, suggesting referral for prosthetics as an independent predictor of long-term survival (p. 8)
- Not everyone will be able to make the return of an in-person VAM in San Diego. Fear not! Many of the key sessions are being livestreamed (p. 10–11)
- Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception (p. 15)
- Corner Stitch: Third-year integrated vascular surgery resident, Madeline Dills, MD, of Louisiana State University, New Orleans, provides valuable insight for trainees on what it’s like taking to the conference podium for the first time (p. 18)
